tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABCL Stock Latest News

AbCellera doses first participants in Phase 1 trial of ABCL575
The FlyAbCellera doses first participants in Phase 1 trial of ABCL575
13d ago
ABCL
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
PremiumCompany Announcements
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
27d ago
ABCL
AbCellera price target raised to $7 from $5 at BMO Capital
PremiumThe Fly
AbCellera price target raised to $7 from $5 at BMO Capital
1M ago
ABCL
AbCellera Biologics Advances Clinical Trials and Revenue Growth
PremiumCompany Announcements
AbCellera Biologics Advances Clinical Trials and Revenue Growth
1M ago
ABCL
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
PremiumRatings
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
1M ago
ABCL
AbCellera Biologics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsAbCellera Biologics Reports Q2 2025 Financial Results
1M ago
8K
ABCL
AbCellera reports Q2 EPS (12c), consensus (16c)
Premium
The Fly
AbCellera reports Q2 EPS (12c), consensus (16c)
1M ago
ABCL
AbCellera assumed with an Outperform at Leerink
Premium
The Fly
AbCellera assumed with an Outperform at Leerink
2M ago
ABCL
AbCellera Biologics Holds Annual Shareholder Meeting
PremiumCompany Announcements
AbCellera Biologics Holds Annual Shareholder Meeting
3M ago
8K
ABCL
Unusually active option classes on open June 11th
PremiumThe Fly
Unusually active option classes on open June 11th
3M ago
FXE
PCG
AbCellera Biologics Receives Health Canada Approval for Trial
PremiumCompany Announcements
AbCellera Biologics Receives Health Canada Approval for Trial
3M ago
8K
ABCL
AbCellera receives Health Canada authorization to initiate ABCL575 Phase 1 trial
PremiumThe Fly
AbCellera receives Health Canada authorization to initiate ABCL575 Phase 1 trial
3M ago
ABCL
AbCellera price target lowered to $10 from $28 at Truist
PremiumThe FlyAbCellera price target lowered to $10 from $28 at Truist
4M ago
ABCL
AbCellera Biologics Receives Health Canada Approval for Trial
Premium
Company Announcements
AbCellera Biologics Receives Health Canada Approval for Trial
4M ago
8K
ABCL
AbCellera receives NOL from Health Canada for ABCL635 clinical trial application
Premium
The Fly
AbCellera receives NOL from Health Canada for ABCL635 clinical trial application
4M ago
ABCL
AbCellera Wins Patent Appeal Against Bruker
PremiumCompany Announcements
AbCellera Wins Patent Appeal Against Bruker
4M ago
8K
ABCL
AbCellera says Federal Circuit rejects Bruker Cellular’s invalidity challenge
PremiumThe Fly
AbCellera says Federal Circuit rejects Bruker Cellular’s invalidity challenge
4M ago
ABCL
BRKR
AbCellera Biologics: Promising Antibody Discovery with Strong Liquidity and Strategic Partnerships
PremiumRatings
AbCellera Biologics: Promising Antibody Discovery with Strong Liquidity and Strategic Partnerships
4M ago
ABCL
AbCellera Biologics Navigates Progress and Challenges in Earnings Call
PremiumCompany Announcements
AbCellera Biologics Navigates Progress and Challenges in Earnings Call
4M ago
ABCL
AbCellera price target lowered to $8 from $10 at Stifel
PremiumThe FlyAbCellera price target lowered to $8 from $10 at Stifel
4M ago
ABCL
AbCellera Biologics Reports Q1 2025 Financial Results
Premium
Company Announcements
AbCellera Biologics Reports Q1 2025 Financial Results
4M ago
ABCL
AbCellera Reports Q1 2025 Financial Results and New Antibody
Premium
Company Announcements
AbCellera Reports Q1 2025 Financial Results and New Antibody
4M ago
8K
ABCL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >